Novo-Rythro Estolate · DIN 00262595 · 50 mg/mL · oral liquid
General benefit; Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.Discontinued June 6, 2018 · checked November 19, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Novo-Rythro Estolate · DIN 00262595
Manufacturer: Novopharm Ltd.; listing date 1996-10-01
Daily cost (source): $1.4260
Health Canada: Cancelled post market since 2018-06-06 · brand NOVO-RYTHRO ESTOLATE SUSPENSION · ATC J01FA01 ERYTHROMYCIN · form Suspension · route Oral · ingredients ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG/5ML · company Teva canada limited · schedule Prescription
Novo-Rythro Estolate: Formulary list price $0.07 per unit (the source does not state the unit; exact figure $0.0713). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00262595)
Source record
DIN 00262595: Novo-Rythro Estolate
Raw flags: sec3=Y
Item: 081212007; group id 23; item number 0038; lccId None; manufacturer id NOP
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0713; ministry $0.0713
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00262595
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1642
Interchangeable products
Ilosone · DIN 00210641 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since June 6, 2018 — choose a marketed DIN from the same-category list.